Andrew Nolting
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Biochemical and Molecular Research, HIV/AIDS drug development and treatment, Synthetic Organic Chemistry Methods, Asymmetric Synthesis and Catalysis, Chemical Synthesis and Analysis
Most-Cited Works
- → Synthesis of Vaniprevir (MK-7009): Lactamization To Prepare a 22-Membered Macrocycle(2011)70 cited
- → Enantioselective Synthesis of α-Methyl-β-cyclopropyldihydrocinnamates(2016)50 cited
- → Synthesis of the C6−C21 Segment of Amphidinolide E(2005)41 cited
- → Design and Synthesis of Novel, Selective GPR40 AgoPAMs(2017)34 cited
- → Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor(2015)33 cited
- → Total Synthesis of Enlicitide Decanoate(2025)30 cited
- → A Modular Synthesis of 2-Alkyl- and 2-Arylchromans via a Three-Step Sequence(2016)25 cited
- → Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Nav1.7 for the Treatment of Pain(2021)21 cited
- → Asymmetric Synthesis of Tertiary and Secondary Cyclopropyl Boronates via Cyclopropanation of Enantioenriched Alkenyl Boronic Esters(2022)18 cited
- → Practical Synthesis of A Macrocyclic HCV Protease Inhibitor: A High-Yielding Macrolactam Formation(2014)17 cited